Post-market Surveillance

A major activity of Inflexxion's Health Analytics group involves the integration and analysis of Inflexxion’s unique proprietary data streams along with publicly available data (e.g., poison control center data, prescription volume data) to better understand and monitor use, abuse, diversion and other negative outcomes associated with potentially abusable products.

All data streams are employed in post-marketing surveillance and epidemiology studies to build a mosaic of research findings intended to capture a complete picture of abuse and abuse-related outcomes associated with a particular product. The data utilized by the Health Analytics team are in near real-time and contribute to the evaluation of abuse deterrent formulations (ADFs) and the impact of public health policies such as the recently implemented Extended-Release and Long-Acting Opioid Analgesics Risk Evaluation and Mitigation Strategy. The Health Analytics team has also employed rigorous analyses in support of new drug applications (NDAs) and preparation and presentation at FDA Advisory Committees.

Request Consultation
Call us at (800) 848-3895